Symbols

TVTX

Travere Therapeutics·NASDAQ

--(--)

TVTX Profile

Travere Therapeutics, Inc.

A company that developing therapies to treat rare disorders like nephrology, hepatology, and metabolism

Industry

Pharmaceutical

Established Date

02/08/2008

Listing Date

01/10/2014

Exchange

NASDAQ Stock Exchange

Full-time Employees

497

Fiscal Year Ends

12-31

Website

travere.com

Security Type

Common stock

Office address

3611 Valley Centre Drive, Suite 300, San Diego, CA 92130

Business

Introduction

Travere Therapeutics, Inc., was incorporated in Oklahoma on February 8, 2008 and re-incorporated in Delaware in February 2011. Travere is an integrated biopharmaceutical company headquartered in San Diego, California, dedicated to developing and delivering life-changing therapies for patients with rare renal and metabolic diseases. The Company regularly evaluates and takes actions as appropriate to expand its product line and approved products through product licensing and acquisitions to meet the unmet medical needs of patients with rare diseases and tap areas that the Company believes have good growth potential.